These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 1086221

  • 1. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
    Gorczynski RM, Knight RA.
    Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221
    [Abstract] [Full Text] [Related]

  • 2. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V, Lahaye T, Horvath C, Zanovello P, Collavo D, Engers HD.
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [Abstract] [Full Text] [Related]

  • 3. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK, Ames RS, McIntire RK, Herberman RB.
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [Abstract] [Full Text] [Related]

  • 4. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F, Jongeneel V, Cerottini JC, Brunner KT.
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [Abstract] [Full Text] [Related]

  • 5. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F, Cerottini JC, Brunner KT.
    Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
    [Abstract] [Full Text] [Related]

  • 6. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW.
    Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
    [Abstract] [Full Text] [Related]

  • 7. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.
    Plater C, Debré P, Leclerc JC.
    Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278
    [Abstract] [Full Text] [Related]

  • 8. T-cell immunity to murine Moloney sarcoma virus-induced tumours: L3T4+ T cells are necessary for resistance to primary sarcoma growth, but Lyt-2+ T cells are required for resistance to secondary tumour cell challenge.
    Bateman WJ, Jenkinson EJ, Owen JJ.
    Immunology; 1987 Jul; 61(3):317-20. PubMed ID: 2956180
    [Abstract] [Full Text] [Related]

  • 9. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract] [Full Text] [Related]

  • 10. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE, Cerottini JC, Brunner KT.
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [Abstract] [Full Text] [Related]

  • 11. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB, Holden HT, Ting CC, Lavrin DL, Kirchner H.
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [Abstract] [Full Text] [Related]

  • 12. Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse.
    Plata F, MacDonald HR, Shain B.
    J Immunol; 1979 Aug; 123(2):852-60. PubMed ID: 156765
    [Abstract] [Full Text] [Related]

  • 13. T cell-mediated immunity to oncornavirus-induced tumors. IV. Preliminary evidence for a specific suppression of anti-Moloney cell-mediated immune response by autoimmune T cells.
    Leclerc JC, Plater C, Connan F, Debré P.
    Eur J Immunol; 1981 Jan; 11(1):45-7. PubMed ID: 6452279
    [Abstract] [Full Text] [Related]

  • 14. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M, Pearson G, Redmon L, Winters E, Kasuga S.
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [Abstract] [Full Text] [Related]

  • 15. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [Abstract] [Full Text] [Related]

  • 16. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC, Burakoff SJ, Faller DV.
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [Abstract] [Full Text] [Related]

  • 17. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW, Whitten HD, Skurzak HM, Andersson B, Lidin B.
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [Abstract] [Full Text] [Related]

  • 18. T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo.
    Leclerc JC, Cantor H.
    J Immunol; 1980 Feb; 124(2):851-4. PubMed ID: 6243333
    [Abstract] [Full Text] [Related]

  • 19. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
    Biasi G, Saggin L, Dazzi F, De Rossi A, Collavo D.
    J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.
    Zanovello P, Vallerani E, Biasi G, Landolfo S, Collavo D.
    J Immunol; 1988 Feb 15; 140(4):1341-4. PubMed ID: 2830339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.